Fc receptor regulation of protective immunity against Chlamydia trachomatis.
about
The Role of the Immune Response in Chlamydia trachomatis Infection of the Male Genital Tract: A Double-Edged SwordAntibody Recognition of Cell Surface-Associated NS1 Triggers Fc- Receptor-Mediated Phagocytosis and Clearance of West Nile Virus-Infected CellsCCL5 regulation of mucosal chlamydial immunity and infection.Protection against Chlamydia promoted by a subunit vaccine (CTH1) compared with a primary intranasal infection in a mouse genital challenge model.Divergent outcomes following transcytosis of IgG targeting intracellular and extracellular chlamydial antigensImmunity to murine chlamydial genital infection.Chlamydia trachomatis polymorphic membrane protein D is a species-common pan-neutralizing antigenInduction of immune memory by a multisubunit chlamydial vaccineImmunization with a MOMP-based vaccine protects mice against a pulmonary Chlamydia challenge and identifies a disconnection between infection and pathologyA Vibrio cholerae ghost-based subunit vaccine induces cross-protective chlamydial immunity that is enhanced by CTA2B, the nontoxic derivative of cholera toxin.Perforin is detrimental to controlling [corrected] C. muridarum replication in vitro, but not in vivo.Characterization of humoral immune responses to chlamydial HSP60, CPAF, and CT795 in inflammatory and severe trachoma.Evaluation of a broadly protective Chlamydia-cholera combination vaccine candidate.Lack of protection following passive transfer of polyclonal highly functional low-dose non-neutralizing antibodiesA limited role for antibody in protective immunity induced by rCPAF and CpG vaccination against primary genital Chlamydia muridarum challenge.A re-evaluation of the role of B cells in protective immunity to Chlamydia infectionTranscutaneous immunization with combined cholera toxin and CpG adjuvant protects against Chlamydia muridarum genital tract infectionAntibody regulation of Tcell immunity: implications for vaccine strategies against intracellular pathogens.Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production.Imiquimod does not affect shedding of viable chlamydiae in a murine model of Chlamydia trachomatis genital tract infectionThe protective efficacy of chlamydial protease-like activity factor vaccination is dependent upon CD4+ T cellsAntibody-mediated immunomodulation: a strategy to improve host responses against microbial antigensPmpG303-311, a protective vaccine epitope that elicits persistent cellular immune responses in Chlamydia muridarum-immune mice.Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine.Delivery of Chlamydia vaccines.A predominant role for antibody in acquired immunity to chlamydial genital tract reinfectionA multi-subunit Chlamydia vaccine inducing neutralizing antibodies and strong IFN-γ⁺ CMI responses protects against a genital infection in minipigsA Multi-Component Prime-Boost Vaccination Regimen with a Consensus MOMP Antigen Enhances Chlamydia trachomatis Clearance.Immune-mediated control of Chlamydia infection.Mechanism of T-cell mediated protection in newborn mice against a Chlamydia infection.Modulation of cytokines and transcription factors (T-Bet and GATA3) in CD4 enriched cervical cells of Chlamydia trachomatis infected fertile and infertile women upon stimulation with chlamydial inclusion membrane proteins B and C.CT043, a protective antigen that induces a CD4+ Th1 response during Chlamydia trachomatis infection in mice and humans.IFNγ is Required for Optimal Antibody-Mediated Immunity against Genital Chlamydia Infection.A novel role for plasmin-mediated degradation of opsonizing antibody in the evasion of host immunity by virulent, but not attenuated, Francisella tularensis.Intranasal immunization with chlamydial protease-like activity factor and CpG deoxynucleotides enhances protective immunity against genital Chlamydia muridarum infection.B cells are essential for moderating the inflammatory response and controlling bacterial multiplication in a mouse model of vaccination against Chlamydophila abortus infectionRole of Fc Receptors as a therapeutic target.The infecting dose of Chlamydia muridarum modulates the innate immune response and ascending infection.Genital Chlamydia trachomatis: understanding the roles of innate and adaptive immunity in vaccine research.A novel whole-bacterial enzyme linked-immunosorbant assay to quantify Chlamydia trachomatis specific antibodies reveals distinct differences between systemic and genital compartments
P2860
Q26851537-9C9C431E-904A-466E-97A2-28C3F014FA17Q27481025-8FA0DBE9-3E9C-475E-AA7B-6A37D9AA4EF0Q33359789-C0DA8DE9-2ED7-4B37-98DB-468B05EF277DQ33588632-CB81CB1C-B56F-4B85-B43E-989327A8737BQ33870404-D1FC8377-6F9D-4411-AB58-F831C1D57D91Q34124225-FD7E4092-89A2-4361-AD0F-4D15B8C82D14Q34478609-C3E9C2FF-9B7A-48B4-9073-7D61C8F8477EQ34546923-2D2E8F96-26FC-4FF9-A04F-23D4EA330D31Q34685461-3307C6EE-EF48-47B3-B20A-7C3ADF99FA5FQ34708547-798FAA1E-E3B8-4E9D-AAF9-E34A80FE432BQ34730267-2C04128D-2028-4445-9A88-0799297187BBQ34735317-FB124962-2ABF-4FEB-9F94-B4405950A5E8Q34883543-1AE963D4-F971-445C-9EEC-0CADC02A6B66Q35167400-EDC02379-AD0E-450D-B3A4-528D9611A33CQ35214742-1AA07D50-AE46-4BCC-85B2-7A31CCD4D284Q35471373-3D7B9ECB-9AD4-43CF-993A-92046C413CF1Q35550138-834AC3F2-CCB9-47D9-A632-675DCA0E403CQ35648247-036F01C7-44D6-48E8-89DC-47F27919B6E9Q35689196-96D0DFEF-0FB2-4B70-979E-BD300754297EQ35751196-18BD482C-0402-4491-BE2A-A57EF5594E5CQ35828850-CE77D80D-4F39-4BC4-A143-3036867A3133Q36017488-90989B88-4DDF-4672-B07C-8C4794F2B7BFQ36018234-1215A03D-261F-4D90-8AAE-2E162D84F785Q36028197-3D072281-069E-464D-ABCA-3A417DCC196CQ36316798-98871F89-9FCD-4811-9C57-ACAFBD012242Q36445638-361187CE-2E09-4416-B76E-17BA9FD15709Q36564785-ADA9B4F1-4E6A-4521-8230-BC0175DF095FQ36845154-416E5120-7AC6-4D4A-9E3C-A639507DEF39Q36990773-8D3E3143-8AE8-4E1C-8F3F-5F6B58C3086EQ37326852-8D281C8F-52A6-4AE5-A60A-B94F4F62F38EQ37331068-1F0FA1AE-0611-4A69-9F54-8147117A1034Q37333434-8AA03EEE-1201-4503-BA83-BEEA1DDCCDBAQ37345928-CF9900B8-61F5-4CCA-80E5-C5923BF59FC8Q37356326-F66B19C3-829B-4C89-9BD4-4B301FEDCE9EQ37376858-DE0771F4-C124-45BB-AFD9-5F7CB9A23642Q37410328-603E7C4F-4286-488F-B973-EC6A8EC61919Q37411578-4B8653C7-E4D4-452C-B8AF-158BFB8F3B31Q37582864-196B5B10-1E35-4BE7-AC1C-EDF7C415771CQ37712799-4772B96F-1742-400F-A4BF-D57407E7F61EQ37833671-C9E70409-2C53-4A35-A5B1-01C0D0FEAC0F
P2860
Fc receptor regulation of protective immunity against Chlamydia trachomatis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2002
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Fc receptor regulation of protective immunity against Chlamydia trachomatis.
@en
Fc receptor regulation of protective immunity against Chlamydia trachomatis.
@nl
type
label
Fc receptor regulation of protective immunity against Chlamydia trachomatis.
@en
Fc receptor regulation of protective immunity against Chlamydia trachomatis.
@nl
prefLabel
Fc receptor regulation of protective immunity against Chlamydia trachomatis.
@en
Fc receptor regulation of protective immunity against Chlamydia trachomatis.
@nl
P2093
P2860
P1433
P1476
Fc receptor regulation of protective immunity against Chlamydia trachomatis.
@en
P2093
Francis O Eko
Godwin A Ananaba
Jacqueline Bolier
Joseph U Igietseme
Samera Bowers
Terri Moore
Tesfaye Belay
P2860
P304
P356
10.1046/J.0019-2805.2001.01354.X
P577
2002-02-01T00:00:00Z